Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.01 per share
-
Shares outstanding
-
39,031,509
-
Total 13F shares
-
10,324,766
-
Share change
-
+10,172,747
-
Total reported value
-
$80,489,118
-
Price per share
-
$7.75
-
Number of holders
-
45
-
Value change
-
+$79,299,231
-
Number of buys
-
41
-
Number of sells
-
1
Institutional Holders of Keenova Therapeutics plc - Ordinary Shares, par value $0.01 per share (MNKTQ) as of Q4 2022
As of 31 Dec 2022,
Keenova Therapeutics plc - Ordinary Shares, par value $0.01 per share (MNKTQ) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,324,766 shares.
The largest 10 holders included
Bracebridge Capital, LLC, JPMORGAN CHASE & CO, Hudson Bay Capital Management LP, FEDERATED HERMES, INC., Sculptor Capital LP, VANGUARD GROUP INC, Alta Fundamental Advisers LLC, Hein Park Capital Management LP, CREDIT SUISSE AG/, and BANK OF MONTREAL /CAN/.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.